Board of Directors
Nancy Harrison, B.Sc., M.B.A.
Nancy Harrison is a co-founder of MSI Methylation Sciences Inc. and is former Senior Vice President of Ventures West Management Inc. Ms. Harrison joined Ventures West in 1993 and focused her efforts on the life sciences sector. Ms. Harrison is one of the most experienced biotech investors in the Canadian venture capital industry and was instrumental in Ventures West's involvement with Angiotech Pharmaceuticals, Inc. (TSE IPO, 1997; NASDAQ, 2000) and AnorMed, Inc. (TSE IPO, 1999) to name a few. In addition to her role at MSI, Ms. Harrison currently donates her time as a Director of several not for profit groups including the Family Services of the North Shore and Providence Health Care. She is a past winner of the Globe and Mail’s Top 40 Under 40 Award, a national program that recognizes the professional and academic achievements of individuals under the age of 40. Ms. Harrison holds a Bachelor of Applied Science (Honours) from Queen's University and a MBA (Honours) from McGill University.
Ms. Harrison is Chair of the Compensation, Corporate Governance and Nominating Committee.